Infections caused by oxa-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 1, 2013, Pages 89-96

  Paño Pardo, José Ramón ^a   Ruiz Carrascoso, Guillermo ^a   Navarro San Francisco, Carolina ^a   Gómez Gil, Rosa ^a   Mora Rillo, Marta ^a   Romero Gómez, María Pilar ^a   Fernández Romero, Natalia ^a   García Rodríguez, Julio ^a   Pérez Blanco, Verónica ^a   Moreno Ramos, Francisco ^a   Mingorance, Jesús ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

Carbapenemases; Hospital spread; Nosocomial

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULFAMETHOXAZOLE; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CATHETER INFECTION; CLINICAL FEATURE; CLONE; COMORBIDITY; FEMALE; GENE; GENE INSERTION SEQUENCE; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; MORTALITY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; SPAIN; SURGICAL INFECTION; TERTIARY HEALTH CARE; TRANSPOSON; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; SPAIN; TERTIARY CARE CENTERS; TIME FACTORS; YOUNG ADULT;

EID: 84870695236     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks364     Document Type: Article

References (40)

1. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 2008; 300: 2911-3.
2. Gupta N, Limbago BM, Patel JB et al. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53: 60-7.
3. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
4. Patel G, Huprikar S, Factor SH et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29: 1099-106.
5. Marchaim D, Navon-Venezia S, Schwaber MJ et al. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008; 52: 1413-8.
6. Daikos GL, Petrikkos P, Psichogiou M et al. Prospective observational study of the impact of VIM-1 metallo-b-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009; 53: 1868-73.
7. Poirel L, Héritier C, Tolün V et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 15-22.
8. Cuzon G, Naas T. Plasmid-mediated carbapenem-hydrolysing OXA-48 b-lactamase in Klebsiella pneumoniae from Tunisia. Int J Antimicrob Agents 2010; 36: 90-1.
9. Benouda A, Touzani O, Khairallah MT et al. First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Ann Trop Med Parasitol 2010; 104: 327-30.
10. Levast M, Poirel L, Carrër A et al. Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France. J Antimicrob Chemother 2011; 66: 944-5.
11. Matar GM, Dandache I, Carrër A et al. Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended-spectrum b-lactamase. Ann Trop Med Parasitol 2010; 104: 271-4.
12. Gülmez D, Woodford N, Palepou M-FI et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008; 31: 523-6.
13. Cuzon G, Naas T, Bogaerts P et al. Plasmid-encoded carbapenemhydrolyzing b-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium. Antimicrob Agents Chemother 2008; 52: 3463-4.
14. Pitart C, Solé M, Roca I et al. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 b-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 2011; 55: 4398-401.
15. Cuzon G, Ouanich J, Gondret R et al. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011; 55: 2420-3.
16. Glupczynski Y, Huang T-D, Bouchahrouf Wet al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents 2012; 39: 168-72.
17. Stone SP, Cooper BS, Kibbler CC et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007; 59: 833-40.
18. Siegel JD, Rhinehart E, Jackson M et al. Management of multidrugresistant organisms in health care settings, 2006. Am J Infect Control 2007; 35 Suppl 2: S165-93.
19. Ciobotaro P, Oved M, Nadir E et al. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011; 39: 671-7.
20. Wiener-Well Y, Rudensky B, Yinnon AM et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect 2010; 74: 344-9.
21. Schechner V, Kotlovsky T, Kazma M et al. Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? Clin Microbiol Infect 2012; Epub ahead of print 6 April 2012; doi: 10.1111/j.1469-0691.2012.03888.
22. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
23. Friedman ND, Kaye KS, Stout JE et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
24. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
25. FDA. Tygacil (Tigecycline) for Injection [package insert]. 2005. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s021lbl. pdf (18 June 2012, date last accessed).
26. CDC. Modified Hodge Test for Carbapenemase Detection in Enterobacteriaceae. 2009. http://www.cdc.gov/HAI/pdfs/labSettings/HodgeTest_Carbapenemase_Enterobacteriaceae.pdf (3 April 2012, date last accessed).
27. Girlich D, Poirel L, Nordmann P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2012; 50: 477-9.
28. Queenan AM, Bush K. Carbapenemases: the versatile b-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
29. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
30. Hindiyeh M, Smollen G, Grossman Z et al. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol 2008; 46: 2879-83.
31. Aubert D, Naas T, Héritier C, Poirel L et al. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of b-lactam resistance genes. J Bacteriol 2006; 188: 6506-14.
32. Healy M, Huong J, Bittner T et al. Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 2005; 43: 199-207.
33. Diancourt L, Passet V, Verhoef J et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-82.
34. Cendejas E, Gómez-Gil R, Gómez-Sánchez P et al. Detection and characterization of Enterobacteriaceae producing metallo-b-lactamases in a tertiary-care hospital in Spain. Clin Microbiol Infect 2010; 16: 181-3.
35. Gómez-Gil MR, Panõ-Pardo JR, Romero-Gõmez MP et al. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother 2010; 65: 2695-7.
36. Souli M, Galani I, Antoniadou A et al. An outbreak of infection due to b-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50: 364-73.
37. Breurec S, Guessennd N, Timinouni M et al. Klebsiella pneumoniae resistant to third-generation cephalosporins in five African and two Vietnamese major towns: multiclonal population structure with two major international clonal groups, CG15 and CG258. Clin Microbiol Infect 2012; Epub ahead of print 15 February 2012; doi: 10.1111/j.1469-0691.2012.03805.x.
38. Potron A, Poirel L, Bussy F et al. Occurrence of the carbapenem-hydrolyzing b-lactamase gene blaOXA-48 in the environment in Morocco. Antimicrob Agents Chemother 2011; 55: 5413-4.
39. Poirel L, Bonnin RA, Nordmann P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 2012; 56: 559-62.
40. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736-55.